Clinical validation of artificial intelligence (AI) is still a long way off, admits Dr. Hugh Harvey, who moderated the Artificial Intelligence Exhibition (AIX) at ECR 2019 with Dr. Wim Van Hecke, CEO of icometrix in Leuven, Belgium. In this interview, Harvey, clinical director at Kheiron Medical, reflects on the future development of AI and the unresolved issues that need to be addressed.
Clinical validation of artificial intelligence (AI) is still a long way off, admits Dr. Hugh Harvey, who comoderated the Artificial Intelligence Exhibition (AIX) with Dr. Wim Van Hecke. He reflects on the future development of AI and the unresolved issues that need to be addressed.Video from ECR 2019: Hugh Harvey on validation of AI
Mar 3, 2019
Latest in Conference
Fujifilm to collaborate with Amazon at ECR 2026
February 13, 2026
AGFA HealthCare to highlight platform advances at ECR 2026
January 29, 2026
Bayer to emphasize phase III clinical trial data at ECR 2026
January 29, 2026
ECR 2026 achieves record number of abstract submissions
January 13, 2026


















